Inquiry Basket
Loading ......
Cardiac inflammation is a key biological process of many cardiovascular diseases, including myocarditis, myocardial infarction, heart failure and atherosclerosis. The accurate quantification of specific inflammatory biomarkers in cardiac research provides valuable insights into disease mechanisms, prognosis, and treatment outcomes. Enzyme linked immunosorbent assay (ELISA) technology has become the gold standard method for accurately detecting and quantifying these biomarkers in various biological samples. With the global aging population and increasing prevalence of cardiovascular disease, the demand for reliable cardiac inflammation assessment tools has never been greater. These test kits enable researchers to monitor the inflammatory cascade that leads to heart damage, remodeling, and dysfunction, ultimately promoting the development of targeted therapies and improved diagnostic strategies.
Figure 1. Types of heart disease.
Cardiac inflammation involves complex interactions between immune cells, cytokines, and acute phase proteins, which trigger and spread inflammatory responses within cardiovascular tissues. Although inflammation is a protective mechanism for tissue repair, excessive or prolonged inflammation activation can lead to harmful outcomes, including fibrosis, impaired contractility, and adverse remodeling.
Figure 2.Structure of C-reactive protein (CRP).
The key biomarkers of cardiac inflammation include:
| Key Biomarkers | Details |
| C-reactive protein (CRP) | An acute phase protein produced by the liver in response to inflammation, particularly in cardiovascular disease. |
| High sensitivity CRP (hs CRP) | A more sensitive detection method that can detect lower CRP concentrations to assess low-grade inflammation associated with cardiovascular risk. |
| Tumor necrosis factor alpha | Tumor necrosis factor alpha (TNF - α) is a pro-inflammatory cytokine that promotes leukocyte activation and endothelial dysfunction in cardiac tissue. |
| Interleukin-6 | Signal molecules that regulate immune cell communication and inflammatory cascade in cardiovascular disease. |
Cardiovascular risk assessment
The quantification of hs CRP has fundamentally changed cardiovascular risk prediction, enabling researchers to identify individuals with elevated baseline inflammatory status who are at greater risk of adverse cardiac events.
Treatment Monitoring
The ELISA kit enables researchers to evaluate the anti-inflammatory effects of cardiovascular therapy in clinical trials. The study of various interventions ranging from medication to lifestyle changes.
Explanation of Disease Mechanisms
The use of these test kits has revealed key insights into the inflammatory pathways driving cardiovascular disease. These findings emphasize the potential of targeting specific inflammatory mechanisms.
Compatibility Assessment of Biomaterials
When researchers evaluate new biomaterials for cardiovascular applications, IgG, IgM, and CRP reactions are typically measured to determine the immunogenicity of the material.
The accurate quantification of key inflammatory biomarkers is the foundation for advancing cardiovascular research. C-reactive protein (CRP) is a key acute phase reactant synthesized by the liver in inflammatory responses and is a sensitive biomarker for infection, tissue damage, and cardiovascular disease. Designing ELISA kits for detecting different species such as mice, rats, and dogs enables researchers to effectively simulate human cardiovascular disease and facilitate translational research from preclinical to clinical settings.
| Product Name | Target Species | Detection Principle | Sample Types | Primary Applications |
| Mouse CRP ELISA Kit | Mouse | Sandwich ELISA | Serum, Plasma, Supernatant | Cardiovascular risk assessment, Inflammation and infection monitoring, Therapeutic efficacy evaluation |
| Rat CRP ELISA Kit | Rat | Sandwich ELISA | Serum, Plasma, Other biological fluids | Preclinical drug development, Acute phase response studies, Safety and toxicology assessment |
| Canine CRP ELISA Kit | Canine (Dog) | Sandwich ELISA | Serum, Plasma | Veterinary cardiology research, Companion animal disease monitoring, Biomarker for canine inflammatory conditions |
The ELISA kit for cardiac inflammation has several unique advantages, making it an indispensable tool for clinical research:
High Sensitivity and Specificity
Modern ELISA kits, especially hs CRP detection, can detect biomarker concentrations at the picogram per milliliter level and even quantify low-grade inflammation. The double antibody sandwich design ensures minimal cross reactivity with relevant molecules.
Quantitative accuracy
These kits provide reliable quantification over a wide dynamic range, with typical intra - and inter batch coefficients of variation below 10%. This precision enables researchers to detect subtle longitudinal changes in the inflammatory state.
Technical accessibility
Unlike specialized techniques that require complex instruments, ELISA platforms are widely used in most research environments, and their simple protocols can produce reproducible results in the laboratory.
Case Study 1: C Reactive Protein Human ELISA Kit in Post-MI Therapy Evaluation
RThe C Reactive Protein Human ELISA Kit provided reliable quantification of post-MI inflammation, validating Drug A’s ability to reduce cardiac tissue damage. This data supported advancing Drug A to Phase III trials.
Case Study 2: hsCRP ELISA Kit in Chronic HF Risk Stratification
The hsCRP ELISA kit can accurately detect low-grade inflammation, confirming that baseline hsCRP is a strong prognostic marker for worsening heart failure. This supports its use in future clinical trials for stratifying HFrEF patients.
We collect and process clinical samples (serum/plasma) to eliminate hemolysis/hyperlipidemia and ensure compliance with pre analytical quality standards prior to testing.
We initialize the ELISA kit by preparing calibration samples constructed from standard curves and running low/high concentration quality control materials.
We add the processed sample to a pre coated microplate, incubate to form a sandwich complex, and perform sequential washing to remove non-specific binding.
We measured absorbance using a microplate reader, and calculated tumor marker concentrations using a validated regression model.
We cross validate the results based on the quality control scope, address potential interferences (such as hook effects), and generate clinically actionable reports.
The ELISA kit for cardiac inflammation is an indispensable tool for advancing cardiovascular research in the era of precision medicine. The ability to accurately quantify inflammatory biomarkers such as CRP and hs CRP deepens our understanding of cardiovascular pathophysiology and opens up new avenues for risk stratification and treatment development. As research continues to uncover the complex interactions between inflammation and cardiac pathology, these tests will play an increasingly important role in identifying new therapeutic targets, guiding targeted anti-inflammatory interventions, and improving cardiovascular outcomes. The continuous improvement of ELISA technology, including increased sensitivity and multiplexing capability, is expected to further expand its practicality in both basic and translational research contexts.
Both detection methods measure the same analyte (C-reactive protein), but the hs CRP kit has been optimized to have higher sensitivity and can detect lower concentrations associated with cardiovascular risk assessment.
Proper sample handling is crucial for reliable results. Blood samples should be collected in serum separation tubes, fully coagulated at room temperature, and promptly centrifuged. The aliquots should be stored at -80 ° C to maintain the stability of biomarkers and avoid repeated freeze-thaw cycles. For hs CRP measurement, samples showing hemolysis or severe hyperlipidemia should be excluded.
Although cardiac inflammatory biomarkers such as CRP and hs CRP are not heart specific, their measurement in the context of clinical presentation, imaging findings, and other biomarkers helps to attribute inflammation to cardiac processes. Research has shown that specific inflammatory patterns, such as elevated hs CRP binding to certain miRNAs, may provide more heart specific information.
Each measurement should include two calibration standards, at least two levels of quality control materials, and appropriate blank holes. Researchers should verify whether the control values are within the expected range and whether the standard curve has appropriate characteristics. Laboratories should participate in external proficiency testing programs when available.
Loading ......
